Cite

HARVARD Citation

    Kagimoto, A. et al. (2021). Preoperative nivolumab to evaluate pathological response in patients with stage I non-small cell lung cancer: a study protocol of phase II trial (POTENTIAL). BMJ open. 11 (3), p. . [Online]. 
  
Back to record